Biosimilars

Latest News

FDA Accepts BLA for Denosumab Biosimilar
FDA Accepts BLA for Denosumab Biosimilar

November 6th 2024

If approved, HLX14 would follow the first 2 denosumab biosimilar approvals in March 2024.

HCPLive Biosimilar Month in Review
Biosimilars Month in Review: October 2024

November 2nd 2024

New Presentation of Ustekinumab Biosimilar Approved for Crohn’s, Ulcerative Colitis
New Presentation of Ustekinumab Biosimilar Approved for Crohn’s, Ulcerative Colitis

October 22nd 2024

Etanercept, Infliximab Biosimilars Not Linked to Greater Infection Risks
Etanercept, Infliximab Biosimilars Not Linked to Greater Infection Risks

October 14th 2024

FDA Approves Ustekinumab (STELARA) Biosimilar for Chronic Inflammatory Diseases
FDA Approves Ustekinumab (STELARA) Biosimilar for Chronic Inflammatory Diseases

October 14th 2024

© 2024 MJH Life Sciences

All rights reserved.